The timeliness of health plan drug coverage policy changes to FDA label revisions. [PDF]
Enright DE +6 more
europepmc +1 more source
From Control to Care: Reframing Medication Access Policies Through Public Health Ethics. [PDF]
Jaffe K, Evans EA.
europepmc +1 more source
Structural Minority Stress Predicts Suicidality, Substance Use, and Sexual Risk Behaviors among Sexual Minority Adolescents. [PDF]
Dellucci TV +6 more
europepmc +1 more source
The practice of drug emergency supply in China during the COVID-19 pandemic: A policy mix perspective. [PDF]
Jie-Ying Z +7 more
europepmc +1 more source
Best Practices and Gaps in Current Regulatory and Health Technology Assessment Real-World Evidence Policies for Medicines and Medical Devices: Current State of Play and Next Steps. [PDF]
Cresswell K +12 more
europepmc +1 more source
Attitudes to Drug Policy in Australia, 2001-2022/23: What Does This Mean for Drug Policy Reform in Australia? [PDF]
Lloyd Z, Roxburgh A.
europepmc +1 more source
Parental preferences for generic substitution policies for children in China: a discrete choice experiment. [PDF]
Pu T +5 more
europepmc +1 more source
Use of clinical outcome assessments in specialty drug coverage policies. [PDF]
Rucker JA +6 more
europepmc +1 more source
Exploring perceptions of cannabis use and employment implications among healthcare workers: a single-institution experience. [PDF]
Lichtenberg AB +6 more
europepmc +1 more source
Effects of pronatal policies on sexual and reproductive health services: a protocol for a scoping review. [PDF]
Mburu G +5 more
europepmc +1 more source

